Delivery Order SPE2DB20D2104-SPE2DB25FNBAF
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order from the Defense Logistics Agency on September 8, 2025, for Diovan HCT 80-12.5 mg tablets (90-count supply) valued at $2,539.28. This firm fixed-price delivery order, with an ultimate completion date of September 9, 2025, carries no set-aside designation and represents a child contract under AmerisourceBergen's larger pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Diovan HCT 160-12.5 mg tablets (90-count) with a ceiling value of $17,047.43. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is due for completion by August 13, 2025. The award was executed from AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- This delivery order, awarded September 16, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides 90 tablets of Diovan HCT 320-12.5 mg at a firm fixed price of $3,057.24. The award is unscheduled and competitively procured without set-aside provisions. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs across military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Diovan HCT 320-12.5 mg tablets (90-count units) with a ceiling value of $2,560.36 and an ultimate completion date of September 8, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating the contract was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- This federal contract award is for the delivery of Diovan HCT 160-25 mg tablets to the Defense Logistics Agency (DLA). The $6,606.30 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on May 12, 2023, with a completion date of May 15, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as the primary vehicle for the company to deliver a comprehensive...
- The Defense Logistics Agency awarded a $3,819.87 delivery order to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 160-12.5 mg tablets (90-count) on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters...
- The U.S. government awarded a Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies. The contract, valued at $30,710.12, is for the provision of Diovan HCT 160-25 mg tablets to the Defense Department's Medical Supply Chain. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued up to $999,999,999.00 through December...
- The Defense Logistics Agency awarded a $7,300.63 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Valsartan-HCTZ 160-12.5 mg tablets (90-count) on June 2, 2025, with completion scheduled for June 3, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00...
- The Defense Logistics Agency awarded a $2,945.03 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Diovan HCT 80-12.5 mg, with a completion date of June 3, 2025. This non-set-aside contract represents a firm fixed price delivery order for pharmaceutical supply and is being performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,904.49 firm-fixed-price contract is for the delivery of Diovan HCT 80-12.5 mg tablets. Amerisourcebergen holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle with a performance period through December 2026. This...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FNBAFDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 19, 2025, for 90 tablets of Diovan HCT 160-12.5 mg, a combination antihypertensive medication. The contract is valued at $8,328.95 with a firm fixed price structure and an ultimate completion date of September 22, 2025. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million through December 2026. The award supports the Defense Logistics Agency's medical supply chain operations, which provide pharmaceutical products and medical supplies to military healthcare systems, the Defense Health Agency, U.S. Coast Guard, and other federal healthcare entities. AmerisourceBergen's substantial IDC vehicle enables the company to supply a comprehensive range of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military medical programs globally. The company's federal contracting history demonstrates its capability to fulfill diverse pharmaceutical procurement requirements through open competition and flexible delivery mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.3k | 9/19/25 |